Literature DB >> 11950210

Copper-psychoactive drug complexes: a voltammetric approach to complexation by 1,4-benzodiazepines.

M M Correia dos Santos1, Vila Famila, M L Simões Gonçalves.   

Abstract

Copper complexation by the 1,4-benzodiazepines medazepam, diazepam, flurazepam, nitrazepam, and clonazepam was investigated using differential pulse polarography and cyclic voltammetry at a mercury electrode in 0.10 M KNO3 and pH 7.0 +/- 0.1. Because the 1,4-benzodiazepines are easily reduced at a mercury electrode through the two-electron reduction of the 4,5-azomethine functional group, copper reduction, as well as that of the ligands, was analyzed under varying experimental conditions. In most situations adsorption phenomena occurred and their influence on voltammetric signals had to be carefully analyzed. The voltammetric behavior was then interpreted in terms of complex formation. The results showed that all benzodiazepines can act as ligands toward copper(II) ions, forming 1:1 and 1:2 complexes with similar stabilities. The stoichiometric acidity constants of the benzodiazepines under study were also determined by potentiometric titration in water-ethanol medium and 0.10 M KNO3 and then extrapolated to 0% concentration of ethanol. (C)2002 Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950210     DOI: 10.1006/abio.2002.5580

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Copper and anesthesia: clinical relevance and management of copper related disorders.

Authors:  Adrian Langley; Charles T Dameron
Journal:  Anesthesiol Res Pract       Date:  2013-05-13

2.  Development of a Flow Injection System for Differential Pulse Amperometry and Its Application for Diazepam Determination.

Authors:  Vesna Antunović; Slavna Tešanović; Danica Perušković; Nikola Stevanović; Rada Baošić; Snežana Mandić; Aleksandar Lolić
Journal:  J Anal Methods Chem       Date:  2018-03-19       Impact factor: 2.193

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.